In a crucial step towards improving paediatric healthcare, the Sankalp India Foundation has opened a new 10-bed Bone Marrow Transplant (BMT) Unit for children with blood abnormalities such as hemoglobinopathies, sickle cell disease, and thalassaemia. This cutting-edge facility, housed at the Health 1 Super Speciality Hospital in Ahmedabad, Gujarat, represents a watershed moment in the region's medical history. It not only offers improved treatment choices, but it also represents a greater commitment to making specialised, life-saving healthcare available to children everywhere.

The Sankalp-Health1 Centre for Paediatric Haematology, Oncology, and BMT is the region's first dedicated BMT unit. The facility was meticulously designed in consultation with prominent medical professionals and made possible by the generous support of many benefactors. It is equipped with cutting-edge equipment to treat life-threatening blood disorders. The facility's revolutionary paperless system streamlines operations, reducing administrative hassles for both patients and their families. This efficiency allows young patients to obtain critical stem cell transplants locally, removing the need for long-distance travel, which has traditionally been a barrier to timely treatment.

The facility's opening was marked by an air of optimism and commitment, attracting notable figures from both the healthcare and corporate realms. Dr. Elke Neujahr, Global CEO of DKMS, and Mr. Shailesh Bhandari, Chairman of Electrotherm India Ltd., attended the opening ceremony. The gathering also paid respect to the late Mechtild Harf of DKMS, in whose memory the BMT unit is named—a moving reminder of the human tales underlying every medical advancement.

Reflecting on the significance of this endeavour, Mr. Rajat Agarwal, president of the Sankalp India Foundation, stated, "The launch of this BMT unit represents a watershed moment for families impacted by blood disorders in Gujarat and abroad." Our dedication to providing the finest possible care for all children remains unwavering. This unit will be a source of hope for families in need of advanced treatment choices.

This dramatic pledge demonstrates the Foundation's continuous commitment to pioneering affordable, high-quality healthcare for underprivileged people, underlining the belief that every child deserves a fighting chance against challenging diseases.

The successful launch of the unit is the result of a combined effort amongst numerous valued partners, including the Cure2Children Foundation, DKMS, Shree Jalaram Abhyudaya Sadbhavna Trust, and Electrotherm India Ltd. Each organisation has contributed significantly to the transformation of a visionary notion into a realistic reality that has the potential to alter paediatric care. Their combined efforts represent not only a deep commitment to social responsibility but also demonstrate how cross-sector collaboration may generate substantial change in healthcare infrastructure.

Aside from the immediate benefits of offering cutting-edge therapy, the BMT unit serves as a model for future healthcare projects in the region. The emphasis on a paperless, technologically enhanced system is especially important because it represents a broader trend of digital innovation in medical services. For many families, the ease of receiving high-quality care without the added stress of travel and paperwork is a welcome relief in an otherwise difficult battle with chronic illness.

Furthermore, we expect this project to have a widespread impact on the community. The unit reduces the need for significant travel, easing the economic and emotional strain on families and leading to better overall outcomes for children undergoing treatment. The holistic strategy of Sankalp India Foundation, combining modern technology, compassionate treatment, and strategic collaborations, sets a high standard for future efforts to address major health challenges in underserved communities.

The new BMT centre in Ahmedabad is more than a medical facility; it is a symbol of optimism, resilience, and development. As it begins operations, the facility aims to bring in a new era of accessible, specialised paediatric care that could potentially serve as a model for similar projects across the country.